These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23146024)

  • 1. The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective.
    Usher K; Park T; Foster K
    J Psychiatr Ment Health Nurs; 2013 Nov; 20(9):801-6. PubMed ID: 23146024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.
    Vandyk AD; Baker C
    Int J Ment Health Nurs; 2012 Aug; 21(4):349-57. PubMed ID: 22404848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia, obesity, and antipsychotic medications: what can we do?
    Citrome L; Vreeland B
    Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the adherence of antipsychotic medication (Aripiprazole) in first-episode psychosis: findings from a grounded theory study.
    Hon A
    J Psychiatr Ment Health Nurs; 2012 May; 19(4):354-61. PubMed ID: 22404328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial processes influencing weight management among persons newly prescribed atypical antipsychotic medications.
    Xiao S; Baker C; Oyewumi LK
    J Psychiatr Ment Health Nurs; 2012 Apr; 19(3):241-7. PubMed ID: 22074295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peers experience of delivering a problem-solving programme to enhance antipsychotic medication adherence for individuals with schizophrenia.
    Boardman G; Kerr D; McCann T
    J Psychiatr Ment Health Nurs; 2015 Aug; 22(6):423-30. PubMed ID: 25944402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients.
    Ryu S; Huh IS; Cho EY; Cho Y; Park T; Yoon SC; Joo YH; Hong KS
    Pharmacopsychiatry; 2016 Mar; 49(2):51-6. PubMed ID: 26845588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of second generation antipsychotics on leptin and ghrelin.
    Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental antipsychotics and metabolic adverse effects--findings from clinical trials.
    Tschoner A; Fleischhacker WW; Ebenbichler CF
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1041-8. PubMed ID: 19777392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients.
    Hashimoto Y; Uno J; Miwa T; Kurihara M; Tanifuji H; Tensho M
    Psychiatry Clin Neurosci; 2012 Aug; 66(5):405-10. PubMed ID: 22834658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia.
    Broder MS; Bates JA; Jing Y; Hebden T; Forbes RA; Chang E
    J Med Econ; 2012; 15(1):105-11. PubMed ID: 21991926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
    Waterreus A; Morgan VA; Castle D; Galletly C; Jablensky A; Di Prinzio P; Shah S
    Aust N Z J Psychiatry; 2012 Aug; 46(8):762-73. PubMed ID: 22689337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight gain associated with taking psychotropic medication: an integrative review.
    McCloughen A; Foster K
    Int J Ment Health Nurs; 2011 Jun; 20(3):202-22. PubMed ID: 21492360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.